Options For Ex-Researchers: From Science's Outer Limits ...

Barbara Stocker is a librarian, Tom Monahan and Mary Boguslaski are patent attorneys, and Randy McBeath is a marketer. Randy Atkins produces television features, and Elizabeth Culotta writes for a newspaper. Ken Freese searches out commercial applications of research at a government laboratory, while Tom Walsh plays a similar role at a university. Yet all have a common background: They were trained as scientists, some with many years of experience as bench researchers or instructors. By applyin

Written bySuzanne Hagan
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

These scientific career switchers represent a small but significant proportion of scientists who are bailing out of career paths that lead to teaching or R&D. One National Science Foundation survey estimates that during 1985, about 8 percent of natural scientists, engineers, and computer specialists opted to leave their fields of training. About 40 percent of those changed occupations to a field outside science, engineering, or computer science.

An exodus of such dimensions troubles labor market planners, most of whom foresee shortages of scientists in the coming decade. Robert C. Dauffenbach, a labor economist at Oklahoma State University, says that "the nature of our national economic growth, coupled with the numbers of people entering the job market and the sorry state of science education at the secondary levels, plus the absence of women and minorities entering science, give us many reasons to be concerned." Making the problem more difficult to examine, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies